MX2023008835A - Métodos de tratamiento de la amiloidosis al. - Google Patents

Métodos de tratamiento de la amiloidosis al.

Info

Publication number
MX2023008835A
MX2023008835A MX2023008835A MX2023008835A MX2023008835A MX 2023008835 A MX2023008835 A MX 2023008835A MX 2023008835 A MX2023008835 A MX 2023008835A MX 2023008835 A MX2023008835 A MX 2023008835A MX 2023008835 A MX2023008835 A MX 2023008835A
Authority
MX
Mexico
Prior art keywords
amyloidosis
methods
treating
patients
treatment
Prior art date
Application number
MX2023008835A
Other languages
English (en)
Spanish (es)
Inventor
Wagner Zago
Gene Kinney
Carol Karp
Radhika Tripuraneni
Original Assignee
Prothena Biosciences Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Prothena Biosciences Ltd filed Critical Prothena Biosciences Ltd
Publication of MX2023008835A publication Critical patent/MX2023008835A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Chemical Treatment Of Metals (AREA)
MX2023008835A 2021-01-29 2022-01-29 Métodos de tratamiento de la amiloidosis al. MX2023008835A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202163143728P 2021-01-29 2021-01-29
PCT/IB2022/050785 WO2022162625A1 (en) 2021-01-29 2022-01-29 Methods of treating al amyloidosis

Publications (1)

Publication Number Publication Date
MX2023008835A true MX2023008835A (es) 2023-09-08

Family

ID=80222587

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2023008835A MX2023008835A (es) 2021-01-29 2022-01-29 Métodos de tratamiento de la amiloidosis al.

Country Status (13)

Country Link
US (1) US20250084153A1 (https=)
EP (1) EP4284829A1 (https=)
JP (1) JP2024505923A (https=)
KR (1) KR20230136643A (https=)
CN (1) CN117098775A (https=)
AU (1) AU2022213010A1 (https=)
CA (1) CA3206326A1 (https=)
CL (1) CL2023002236A1 (https=)
IL (1) IL304755A (https=)
JO (1) JOP20230172A1 (https=)
MX (1) MX2023008835A (https=)
TW (1) TW202332465A (https=)
WO (1) WO2022162625A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH12021552135A1 (en) 2019-03-05 2022-08-31 Prothena Biosciences Ltd Methods of treating al amyloidosis

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018005967A1 (en) * 2016-06-30 2018-01-04 Prothena Therapeutics Limited Compositions for treating amyloidosis
US11382974B2 (en) * 2017-08-01 2022-07-12 The Trustees Of Columbia University In The City Of New York Methods and compositions for treatment of amyloid deposition diseases
PH12021552135A1 (en) * 2019-03-05 2022-08-31 Prothena Biosciences Ltd Methods of treating al amyloidosis

Also Published As

Publication number Publication date
US20250084153A1 (en) 2025-03-13
EP4284829A1 (en) 2023-12-06
JOP20230172A1 (ar) 2023-07-27
KR20230136643A (ko) 2023-09-26
IL304755A (en) 2023-09-01
CL2023002236A1 (es) 2024-02-09
CN117098775A (zh) 2023-11-21
AU2022213010A1 (en) 2023-08-17
WO2022162625A1 (en) 2022-08-04
AU2022213010A9 (en) 2024-09-26
TW202332465A (zh) 2023-08-16
CA3206326A1 (en) 2022-08-04
JP2024505923A (ja) 2024-02-08

Similar Documents

Publication Publication Date Title
JOP20210245A1 (ar) طرق لعلاج الداء النشواني من النوع خفيف السلسلة
JOP20240161A1 (ar) طرق لعلاج الخاضعين المصابين بالصدفية اللويحية لفروة الرأس
ZA202304965B (en) Combination therapy for treating cancer
MX2024014121A (es) Metodos y composiciones para el tratamiento del exceso de glucocorticoides
MA69153A1 (fr) Méthodes de traitement d'une splénomégalie
SA522431538B1 (ar) طُرق وتركيبات لعلاج تساقط الشعر
MX2024001954A (es) Anticuerpos il-13 para el tratamiento de la dermatitis atopica.
MX2025000673A (es) Metodos de administracion de nalbufina
MX2024008652A (es) Métodos para tratar la amiloidosis al.
MX2023008835A (es) Métodos de tratamiento de la amiloidosis al.
MX2023003583A (es) Forma cristalina del compuesto de piridinilfenilo y metodo de preparacion del mismo.
MX2020008881A (es) Métodos de tratamiento contra el cáncer que comprenden inhibidores de chk1.
MX2022012632A (es) Uso de inhibidores del bromodominio para el tratamiento de la enfermedad de huntington.
PH12022551021A1 (en) Sequential anti-cd19 therapy
MX2025005552A (es) Metodos para tratar o prevenir la amiloidosis mediada por transtiretina
WO2019179823A8 (en) Lactobacillus fermentum for treating fructose-related diseases
MX2024015040A (es) Fitusiran para el tratamiento de la hemofilia a y b en pacientes pediatricos
MX2022011027A (es) Composiciones y metodos para el tratamiento del cancer.
WO2021257695A3 (en) Methods and compositions related to neutralizing antibodies against human coronavirus
MX2024002684A (es) Metodos para la prevencion y tratamiento de sinucleinopatias.
MX2022013883A (es) Compuestos de metiltioninio para uso en el tratamiento de covid-19.
MX2021012130A (es) Combinaciones de inhibidores de transcripción e inhibidores de punto de control inmuneitario para el tratamiento de enfermedad.
MX2025012588A (es) Tratamiento de la diabetes mellitus
MX2022013885A (es) Compuestos de metiltioninio para uso en el tratamiento de covid-19.
MX2025006477A (es) Metodos de administracion de belumosudil para el tratamiento del mieloma multiple